Lumos Pharma (LUMO) Q2 2024 Earnings

May 14Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.29
-1.21
-1.12
-1.04

Details

Expected EPS
-1.136
Actual EPS
-1.29
Surprise EPS
-0.15
Surprise Percent
-13.56%

Description

⁨Lumos Pharma⁩ (⁦LUMO⁩) has reported earnings of ⁦-1.29⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts